Daniel Joseph Apel, CFO of Arrowhead Pharmaceuticals ARWR, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $934.3K. The latest trade was on 04/22.

DA

DA

Daniel Joseph Apel

CFO

Company

Arrowhead Pharmaceuticals ARWR

First filing

26/01/08

Trades

4 trades

Buys / sales

0 / 3

12-month net buying

−$934.3K

Last trade

04/22

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Arrowhead PharmaceuticalsARWR	Open-market sale10b5-1 plan	04/22	04/24	13,095 sh3 trades	$71.35avg.	$934,285.13	−7.4%